Type: All cancers

A/Prof Swarbrick and his team will study multiple solid cancers that have a range of responses to immunotherapy. The team will identify which types of stromal cells block immune responses to cancer and how they do this.

Prof Price is investigating how new imaging technology could be used to enhance radiotherapy effectiveness in solid cancers. 

Researchers will test a more targeted treatment approach in greatly improving outcomes for individual children with advanced neuroblastoma.

Dr Jeremy Booth and his team will use tracking technology during radiation treatment for prostate, liver and pancreas cancer patients.

Researchers will develop a new website that assesses symptoms of cancer survivors and recommends care based on how severe the symptoms are

Associate Professor Hilda Pickett

A/Prof Pickett has developed a potential new drug that targets the process cancers use to grow and survive.

Research has revealed that most food ads kids see on public transport are for junk food, despite growing rates of childhood obesity.

This project will focus on developing adaptive radiotherapy for locally advanced lung, prostate and oligometastatic cancer.

Professor Liu and his team are investigating how particular proteins affect the development and growth of tumours in children with TERT-rearranged neuroblastoma.